Anomaly Bio engineers microbes as micro-factories to produce scalable, eco-friendly bio-ingredients, replacing fragile supply chains.
Anomaly Bio has raised $2.6M in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2025.
Anomaly Bio's investors include Pebblebed, Akshay Kothari, Mithun Sacheti, Sean Hunt, Eben Bayer.
Anomaly Bio is headquartered in Singapore, Singapore.
Anomaly Bio engineers microbes as micro-factories to produce scalable, eco-friendly bio-ingredients, replacing fragile supply chains.
Anomaly Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anomaly Bio — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/anomaly-bio. Accessed August 14, 2026.
VCBacked. (2025). Anomaly Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/anomaly-bio
{{cite web |title=Anomaly Bio — Funding & Investors |url=https://www.vcbacked.co/company/anomaly-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated